ArticleAdvanced healthcare materials2026
Tunable Bioresorbable Scaffolds With Marine Sulfated Polysaccharides for Small-Caliber Vascular Grafts: A Multi-Layered Strategy Combining Electrospinning and 4-Axis Printing.
Article in Advanced healthcare materials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Copolymers of Poly(Butylene Trans-1,4-Cyclohexanedicarboxylate)/Pripol as New Biomaterial Platform for Small Diameter Vascular Graft.Advanced healthcare materials · 2026Article
- Barriers to clinical translation of small-diameter tissue-engineered vascular grafts in peripheral reconstruction.JVS-vascular science · 2026Review
- Tissue-engineered blood vessels for clinical translation: Design logic, representative advances and persistent barriers.Journal of tissue engineeringReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
The development of small-caliber tissue-engineered vascular grafts (sTEVGs) presents several challenges, including achieving balanced endothelialization, facilitating smooth muscle cell infiltration, preventing leakage, and ensuring anti-thrombogenic properties, while maintaining mechanical strength sufficient to withstand physiological pressures, surgical handling, and suturing. Here, we present a multi-layered polycaprolactone (PCL)-based sTEVG using a combination of electrospinning and 4-axis printing, providing precise control over scaffold porosity, fiber alignment, and tunable mechanical properties. To improve biocompatibility and hemocompatibility, the PCL nanofibers were functionalized with sulfated polysaccharides purified from the marine invertebrate Holothuria tubulosa, which significantly enhanced endothelialization and provided strong anti-thrombogenic properties. The inner layer of tightly aligned electrospun nanofibers supported rapid formation of a mature endothelium, while preventing graft leakage even at supraphysiological pressure (>1100 mmHg). The middle layers, combining circumferential electrospun nanofibers and 4-axis printed microfibers, increased scaffold porosity, and promoted adhesion, orientation and infiltration of human coronary artery smooth muscle cells (HCASMCs), facilitating functional tunica media formation. The outer layer of randomly oriented electrospun nanofibers contributed significantly to the mechanical properties of the graft, namely elasticity, toughness, burst pressure, and resistance to physiological vessel pressures, thus mimicking the tunica adventitia. The customizable four-layered graft integrates structural and biological cues to address key limitations of sTEVGs, representing a valuableoff-the-shelf alternative to autologous grafts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.